BD5 Human

Beta Defensin-5 Human Recombinant
Cat. No.
BT14352
Source
Escherichia Coli.
Synonyms
Beta-defensin 105, eta-defensin 5, BD-5, DEFB-5, Defensin, beta 105, DEFB105A, BD5, DEFB105, DEFB5, DEFB105B.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

BD5 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 51 amino acids and having a molecular mass of 5.8 kDa. The Beta Defensin-5 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Defensins, encompassing both alpha and beta types, are positively charged peptides that exhibit a broad spectrum of antimicrobial activity, representing a crucial component of the innate immune system. Humans possess six beta-defensins: BD-1, BD-2, BD-3, BD-4, BD-5, and BD-6. These defensins are found on certain white blood cells and epithelial surfaces. In addition to their direct antimicrobial properties, beta-defensins can function as chemoattractants, guiding immature dendritic cells and memory T cells. Structurally, beta-defensins possess a distinct motif of six cysteine residues that form three intramolecular disulfide bonds.
Description
Recombinant human BD5, produced in E. coli, is a single, non-glycosylated polypeptide chain composed of 51 amino acids, resulting in a molecular weight of 5.8 kDa. The purification of Beta Defensin-5 is achieved through proprietary chromatographic methods.
Physical Appearance
Sterile, white powder obtained through lyophilization (freeze-drying).
Formulation
Lyophilized from a 0.2 µm filtered concentrated solution in phosphate-buffered saline (PBS) at a pH of 7.4.
Solubility
To reconstitute the lyophilized Beta Defensin-5, it is advised to dissolve it in sterile 18 MΩ·cm H₂O at a concentration of at least 100 µg/ml. Subsequently, it can be further diluted in other aqueous solutions.
Stability
Lyophilized Beta Defensin-5 demonstrates stability at room temperature for a duration of 3 weeks. However, for optimal storage, it is recommended to keep it desiccated at a temperature below -18°C. Following reconstitution, BD5 should be stored at 4°C for a period of 2 to 7 days. For extended storage, it is advisable to store it below -18°C. To ensure long-term stability during storage, the addition of a carrier protein (0.1% HSA or BSA) is recommended. It is crucial to avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 95.0% through the following methods: (a) Analysis by reverse-phase high-performance liquid chromatography (RP-HPLC). (b) Analysis by sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Synonyms
Beta-defensin 105, eta-defensin 5, BD-5, DEFB-5, Defensin, beta 105, DEFB105A, BD5, DEFB105, DEFB5, DEFB105B.
Source
Escherichia Coli.
Amino Acid Sequence
GLDFSQPFPS GEFAVCESCK LGRGKCRKEC LENEKPDGNC RLNFLCCRQR I.

Product Science Overview

Introduction

Beta Defensin-5 (hBD-5) is a member of the beta-defensin family, which are small cationic peptides known for their broad-spectrum antimicrobial properties. These peptides play a crucial role in the innate immune system by providing the first line of defense against pathogens. The recombinant form of Beta Defensin-5 is produced using advanced biotechnological methods, making it a valuable tool for research and potential therapeutic applications.

Characteristics

Beta Defensin-5 is a peptide consisting of 51 amino acids with a molecular mass of approximately 5.8 kDa . It is characterized by a six-cysteine motif that forms three intramolecular disulfide bonds, which are essential for its stability and function . The peptide is typically produced in Escherichia coli (E. coli) and purified using proprietary chromatographic techniques to achieve a purity greater than 95% .

Mode of Action

Beta Defensin-5 exhibits antimicrobial activity by disrupting the membrane integrity of bacteria, fungi, and viruses. It achieves this through its cationic nature, which allows it to interact with the negatively charged microbial membranes, leading to membrane permeabilization and cell death . Additionally, Beta Defensin-5 can act as a chemoattractant for immature dendritic cells and memory T cells, thereby enhancing the immune response .

Production and Stability

The recombinant form of Beta Defensin-5 is produced in E. coli and is available as a lyophilized (freeze-dried) powder . It is recommended to reconstitute the lyophilized peptide in sterile water to a concentration of at least 100 µg/ml, which can then be further diluted as needed . The lyophilized form is stable at room temperature for up to three weeks, but for long-term storage, it should be kept desiccated below -18°C . Once reconstituted, the peptide should be stored at 4°C for short-term use and below -18°C for long-term use, with the addition of a carrier protein to prevent freeze-thaw cycles .

Applications

Beta Defensin-5 has promising therapeutic applications due to its antimicrobial properties. It is being studied for its potential use in treating drug-resistant infections, enhancing wound healing, and as an adjuvant in vaccines . Its ability to modulate the immune response also makes it a candidate for research in autoimmune diseases and cancer .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.